Nilewar, S.S.; Khanra, S.; Pandya, M.; Lodha, S.; Kumar, P.K.; Bandaru, N.; Naranjo-Redondo, A.J.; Pérez-Pastén-Borja, R.; Pawar, T.J.
Exploiting the T790M Gatekeeper: A Theoretical Blueprint for Non-Covalent Inhibition of in cis Triple-Mutant EGFR. Pharmaceutics 2026, 18, 842.
https://doi.org/10.3390/pharmaceutics18070842
AMA Style
Nilewar SS, Khanra S, Pandya M, Lodha S, Kumar PK, Bandaru N, Naranjo-Redondo AJ, Pérez-Pastén-Borja R, Pawar TJ.
Exploiting the T790M Gatekeeper: A Theoretical Blueprint for Non-Covalent Inhibition of in cis Triple-Mutant EGFR. Pharmaceutics. 2026; 18(7):842.
https://doi.org/10.3390/pharmaceutics18070842
Chicago/Turabian Style
Nilewar, Shrikant S., Shuvadip Khanra, Manav Pandya, Sandesh Lodha, Perli Kranti Kumar, Nagaraju Bandaru, Antonio Jose Naranjo-Redondo, Ricardo Pérez-Pastén-Borja, and Tushar Janardan Pawar.
2026. "Exploiting the T790M Gatekeeper: A Theoretical Blueprint for Non-Covalent Inhibition of in cis Triple-Mutant EGFR" Pharmaceutics 18, no. 7: 842.
https://doi.org/10.3390/pharmaceutics18070842
APA Style
Nilewar, S. S., Khanra, S., Pandya, M., Lodha, S., Kumar, P. K., Bandaru, N., Naranjo-Redondo, A. J., Pérez-Pastén-Borja, R., & Pawar, T. J.
(2026). Exploiting the T790M Gatekeeper: A Theoretical Blueprint for Non-Covalent Inhibition of in cis Triple-Mutant EGFR. Pharmaceutics, 18(7), 842.
https://doi.org/10.3390/pharmaceutics18070842
